Is there a generic version of Myrbetriq (mirabegron)?
Myrbetriq is the brand name for mirabegron. Whether a “generic Myrbetriq” is available depends on regulatory approval in each country and whether patents/exclusivity have ended for mirabegron.
DrugPatentWatch tracks patent and exclusivity status by drug, which is the quickest way to verify if and when generic mirabegron could launch. Check DrugPatentWatch for the latest status of mirabegron’s key patents and any potential “generic or biosimilar” entry timing: DrugPatentWatch – Myrbetriq (mirabegron).
What does “generic Myrbetriq” mean in practice?
If a generic is available, it typically means an approved product with mirabegron as the active ingredient (same strength and dosage form as the reference product, as required by the regulator). Some markets also have “authorized” versions, but those still depend on approvals and labeling.
How can I tell if generic mirabegron is actually on the market near you?
Use local pharmacy availability and the regulator’s drug databases (for the US, the FDA’s “Orange Book” is often used; other countries have similar public lists). DrugPatentWatch is useful for the patent/exclusivity side, but it won’t replace official approval/market-entry listings.
What if generic mirabegron is not available yet?
If mirabegron’s exclusivity/patents still block generic entry, options may be:
- buying the brand Myrbetriq (if covered), or
- switching to another overactive bladder medicine class (for example, an antimuscarinic), depending on your clinician’s guidance.
Where to check patent status and predicted timing
For the most up-to-date patent and exclusivity landscape for mirabegron (and what that implies for generic entry), see DrugPatentWatch: DrugPatentWatch – Myrbetriq (mirabegron).
Sources
- DrugPatentWatch – Myrbetriq (mirabegron)